Direct Acting Antiviral-Post Authorization Safety Study
Completed
Conditions studied: Hepatitis C, Hepatocellular Carcinoma
In brief
This is an independent optional sub-study parallel to TARGET-HCC (NCT02954094). The purpose of Direct-Acting Antiviral-Post Authorization Safety Study (DAA-PASS) is to investigate the impact of exposure to direct-acting antivirals (DAAs) on early recurrence of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV)-infected patients following successful HCC treatment interventions.
Key facts
- Study ID
- NCT03707080
- Run by
- Target PharmaSolutions, Inc.
- People needed
- 42
- Starts
- 2018-03-09
- Expected to finish
- 2021-06-30
- Last updated by the study team
- 2021-07-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Stanford University — Palo Alto, California, United States
- California Liver Research Institute — Pasadena, California, United States
- University of California - Davis Clinical Trials — Sacramento, California, United States
- University of California - San Francisco — San Francisco, California, United States
- Georgetown University — Washington D.C., District of Columbia, United States
- Gastro Florida — Clearwater, Florida, United States
- University of Florida Hepatology Research at CTRB — Gainesville, Florida, United States
- University of Florida - Health Gastroenerology — Jacksonville, Florida, United States
- Schiff Center for Liver Diseases — Miami, Florida, United States
- Tampa General Medical Group — Tampa, Florida, United States
- Piedmont Atlanta Hospital — Atlanta, Georgia, United States
- Emory University Hospital — Atlanta, Georgia, United States
- Northwestern University Division of Gastroenterology and Hepatology — Chicago, Illinois, United States
- Rush University Medical Center — Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Tulane University School of Medicine — New Orleans, Louisiana, United States
- Mercy Medical Center — Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Henry Ford Health System — Detroit, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Southern Therapy and Advanced Research LLC — Jackson, Mississippi, United States
- Banner University Medical Center — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.